AstraZeneca-Daiichi Sankyo breast cancer drug shows promise

British drugmaker AstraZeneca and Japan's Daiichi Sankyo said on Wednesday their experimental treatment for breast cancer met its key goal in a mid-stage study, bolstering their defenses in a highly competitive oncology market.